U.S. Bankruptcy Judge Robert Drain of the Bankruptcy Court for the Southern District of New York on Wednesday said he will approve the $4.5 billion settlement for the bankruptcy of Purdue Pharma, the company that produced and marketed OxyContin, after two tweaks are made to the proposed settlement.